Featured Research

from universities, journals, and other organizations

Study Points To Relief From Seasonal Allergies

Date:
October 31, 2007
Source:
Creighton University
Summary:
The results of a new study may soon spell relief for some of the estimated 40 million Americans who suffer from seasonal allergic rhinitis caused by pollens such as grass and ragweed. According to researchers, noninhaled, intranasal carbon dioxide may offer a new, effective and safe treatment for many SAR sufferers.

The results of a new Creighton University study may soon spell relief for some of the estimated 40 million Americans who suffer from seasonal allergic rhinitis (SAR) caused by pollens such as grass and ragweed.

According to Creighton researchers, noninhaled, intranasal carbon dioxide (CO2) may offer a new, effective and safe treatment for many SAR sufferers. The study will be reported in an upcoming issue of the Journal of Allergy & Clinical Immunology.

“These findings indicate that noninhaled, intranasal carbon dioxide is very promising as a safe and effective treatment to provide rapid relief for seasonal allergic rhinitis. With the exception of a burning/stinging sensation when the carbon dioxide is first administered, there appears to be no significant side effects with this technique.

“It could be a good alternative for people who don’t want to take intranasal steroids,” said Thomas B. Casale, M.D., principal investigator and chief of Creighton School of Medicine’s Division of Allergy/Immunology.

Currently, there are no treatments available that provide truly rapid relief of SAR symptoms and can be used safely long-term, he added.

In the Creighton study, patients receiving CO2 reported a significant and rapid improvement in congestion, sneezing and other nasal symptoms – within 10 minutes and lasting at least 24 hours – over those taking a placebo (plain air). The CO2 group also reported some, although not statistically significant, improvement in non-nasal symptoms such as watery and itchy eyes.

Within 30 minutes of treatment, 50 percent of those taking CO2 reported more than a 50 percent improvement in nasal symptoms, compared to 27.6 percent of the placebo group.

The Creighton study involved 89 subjects, 18 to 75 years of age, who had at least a two-year history of seasonal allergies requiring pharmacotherapy. Sixty received CO2 and 29 received plain air.

The patients took the gases intranasally twice – once for each nostril – within an interval of less than five minutes for a total dose of about 1,200 milliliters. They avoided inhaling the gas by breathing through the mouth, allowing the gas to flow in one nostril, pass through the nose and sinus cavities, and pass out the other nostril.

The use of intranasal noninhaled CO2 has already proven effective in treating migraines, although it is not yet approved by the U.S. Food and Drug Administration for that use. Allergic rhinitis is triggered by some of the same mechanisms as migraines.

Casale noted that, despite currently available treatments, a significant proportion of patients with allergic rhinitis continue to suffer symptoms that impair their quality of life and can lead to other conditions such as asthma. The medical costs associated with SAR are estimated at $6 billion annually in the United States alone, he said.


Story Source:

The above story is based on materials provided by Creighton University. Note: Materials may be edited for content and length.


Cite This Page:

Creighton University. "Study Points To Relief From Seasonal Allergies." ScienceDaily. ScienceDaily, 31 October 2007. <www.sciencedaily.com/releases/2007/10/071030105013.htm>.
Creighton University. (2007, October 31). Study Points To Relief From Seasonal Allergies. ScienceDaily. Retrieved July 24, 2014 from www.sciencedaily.com/releases/2007/10/071030105013.htm
Creighton University. "Study Points To Relief From Seasonal Allergies." ScienceDaily. www.sciencedaily.com/releases/2007/10/071030105013.htm (accessed July 24, 2014).

Share This




More Health & Medicine News

Thursday, July 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Idaho Boy Helps Brother With Disabilities Complete Triathlon

Idaho Boy Helps Brother With Disabilities Complete Triathlon

Newsy (July 23, 2014) An 8-year-old boy helped his younger brother, who has a rare genetic condition that's confined him to a wheelchair, finish a triathlon. Video provided by Newsy
Powered by NewsLook.com
Thousands Who Can't Afford Medical Care Flock to Free US Clinic

Thousands Who Can't Afford Medical Care Flock to Free US Clinic

AFP (July 23, 2014) America may be the world’s richest country, but in terms of healthcare, the World Health Organisation ranks it 37th. Thousands turned out for a free clinic run by "Remote Area Medical" with a visit from the Governor of Virginia. Duration: 2:40 Video provided by AFP
Powered by NewsLook.com
Stone Fruit Listeria Scare Causes Sweeping Recall

Stone Fruit Listeria Scare Causes Sweeping Recall

Newsy (July 22, 2014) The Wawona Packing Company has issued a voluntary recall on the stone fruit it distributes due to a possible Listeria outbreak. Video provided by Newsy
Powered by NewsLook.com
Huge Schizophrenia Study Finds Dozens Of New Genetic Causes

Huge Schizophrenia Study Finds Dozens Of New Genetic Causes

Newsy (July 22, 2014) The 83 new genetic markers could open dozens of new avenues for schizophrenia treatment research. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins